Market Research Logo

In Vitro Diagnostics - Global Market Outlook (2015-2022)

In Vitro Diagnostics - Global Market Outlook (2015-2022)

According to Stratistics MRC, the Global In Vitro Diagnostics market is accounted for $61.65 billion in 2015 and is expected to reach $94.57 billion by 2022 growing at a CAGR of 6.3%. Technologically advanced healthcare and consumer spending in market is helping the market growth. Polluted environment and contaminated surroundings are leading to increase in number of chronic disease and infections, these all factors are favoring the market to grow. Moreover widely spread knowledge and cost effectiveness are also driving the market. But stringent regulations and reimbursement issues are hampering the market growth.

However Infectious disease in application segment is anticipated to grow at considerable pace due to rise in amount of infectious diseases and it is followed by HIV/AIDS application. Whereas Laboratories in end-user segment is estimated to grow fast because of rise in number of laboratories, followed by Point of Care Diagnostics. North America being the largest revenue market, Asia Pacific is expected to grow fast due to increasing number of End-User applications.

Some of the major key players in the market are Roche Diagnostics Bio-Rad Laboratories, Inc., Johnson and Johnson , Biomérieux, Siemens Healthcare, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Cepheid Inc , Alere Inc., Novartis and Leica Biosystems.

Applications Covered:
Diabetes
Autoimmune Diseases
Cardiology
Drug Testing
HIV/AIDS
Infectious Diseases
Nephrology
Oncology/Cancer
Other Applications
Product & Services Covered:
Data Management Software/Hardware
Instruments
Reagents & Kits
Services
Technologies Covered:
Immunochemistry/Immunoassays
Elisa
 Chemiluminescence Immunoassays (CLIAs)
 Colorimetric Immunoassays (CI)
 Fluorescence Immunoassays (FIA)
Western Blot
Rapid Tests
Radioimmunoassay’s (RIA)
Elispot
Coagulation and Hemostasis
Molecular Diagnostics (MDX)
DNA Sequencing & Next-Generation Sequencing
Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Polymerase Chain Reaction (PCR)
Other Molecular Diagnostics
Hematology
Microbiology
Clinical Chemistry
Electrolyte Panels
Basic Metabolic Panel
Lipid Profiles
Liver Panels
Renal Profiles
Specialty Chemical Tests
Thyroid Function Panels
Other Technologies
End-Users Covered:
Academic Institutes
Hospitals
Laboratories
Patient Self-Testing
Point-Of-Care Testing
Other End-Users

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Technology Analysis
3.9 End-User Analysis
3.10 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global In Vitro Diagnostics Market, By Application
5.1 Introduction
5.2 Diabetes
5.3 Autoimmune Diseases
5.4 Cardiology
5.5 Drug Testing
5.6 HIV/AIDS
5.7 Infectious Diseases
5.8 Nephrology
5.9 Oncology/Cancer
5.10 Other Applications
6 Global In Vitro Diagnostics Market, By Product & Service
6.1 Introduction
6.2 Data Management Software/Hardware
6.3 Instruments
6.4 Reagents & Kits
6.5 Services
7 Global In Vitro Diagnostics Market, By Technology
7.1 Introduction
7.2 Immunochemistry/Immunoassays
7.2.1 Elisa
7.2.1.1 Chemiluminescence Immunoassays (CLIAs)
7.2.1.2 Colorimetric Immunoassays (CI)
7.2.1.3 Fluorescence Immunoassays (FIA)
7.2.2 Western Blot
7.2.3 Rapid Tests
7.2.4 Radioimmunoassays (RIA)
7.2.5 Elispot
7.3 Coagulation and Hemostasis
7.4 Molecular Diagnostics (MDX)
7.4.1 DNA Sequencing & Next-Generation Sequencing
7.4.2 Hybridization
7.4.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
7.4.4 Microarrays
7.4.5 Polymerase Chain Reaction (PCR)
7.4.6 Other Molecular Diagnostics
7.5 Hematology
7.6 Microbiology
7.7 Clinical Chemistry
7.7.1 Electrolyte Panels
7.7.2 Basic Metabolic Panel
7.7.3 Lipid Profiles
7.7.4 Liver Panels
7.7.5 Renal Profiles
7.7.6 Specialty Chemical Tests
7.7.7 Thyroid Function Panels
7.8 Other Technologies
8 Global In Vitro Diagnostics Market, By End-User
8.1 Introduction
8.2 Academic Institutes
8.3 Hospitals
8.4 Laboratories
8.5 Patient Self-Testing
8.6 Point-Of-Care Testing
8.7 Other End-Users
9 Global In Vitro Diagnostics Market, By Geography
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Roche Diagnostics
11.2 Bio-Rad Laboratories, Inc.
11.3 Johnson and Johnson
11.4 Biomérieux
11.5 Siemens Healthcare
11.6 Abbott Laboratories, Inc.
11.7 Thermo Fisher Scientific, Inc.
11.8 Ortho Clinical Diagnostics, Inc.
11.9 Danaher Corporation
11.10 Sysmex Corporation
11.11 Becton, Dickinson and Company
11.12 Cepheid Inc
11.13 Alere Inc.
11.14 Novartis
11.15 Leica Biosystems
List of Tables
Table 1 Global In Vitro Diagnostics Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 3 Global In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
Table 4 Global In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 5 Global In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
Table 6 Global In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
Table 7 Global In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
Table 8 Global In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 9 Global In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
Table 10 Global In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
Table 11 Global In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 12 Global In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
Table 13 Global In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
Table 14 Global In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
Table 15 Global In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
Table 16 Global In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
Table 17 Global In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 18 Global In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
Table 19 Global In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
Table 20 Global In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
Table 21 Global In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 22 Global In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
Table 23 Global In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
Table 24 Global In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
Table 25 Global In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
Table 26 Global In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
Table 27 Global In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
Table 28 Global In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
Table 29 Global In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
Table 30 Global In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 31 Global In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
Table 32 Global In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
Table 33 Global In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
Table 34 Global In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
Table 35 Global In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
Table 36 Global In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
Table 37 Global In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
Table 38 Global In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
Table 39 Global In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
Table 40 Global In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
Table 41 Global In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
Table 42 Global In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
Table 43 Global In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
Table 44 Global In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
Table 45 Global In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 46 Global In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
Table 47 Global In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
Table 48 Global In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
Table 49 Global In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
Table 50 North America In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
Table 51 North America In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 52 North America In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
Table 53 North America In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 54 North America In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
Table 55 North America In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
Table 56 North America In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
Table 57 North America In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 58 North America In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
Table 59 North America In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
Table 60 North America In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 61 North America In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
Table 62 North America In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
Table 63 North America In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
Table 64 North America In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
Table 65 North America In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
Table 66 North America In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 67 North America In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
Table 68 North America In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
Table 69 North America In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
Table 70 North America In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 71 North America In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
Table 72 North America In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
Table 73 North America In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
Table 74 North America In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
Table 75 North America In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
Table 76 North America In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
Table 77 North America In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
Table 78 North America In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
Table 79 North America In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 80 North America In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
Table 81 North America In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
Table 82 North America In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
Table 83 North America In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
Table 84 North America In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
Table 85 North America In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
Table 86 North America In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
Table 87 North America In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
Table 88 North America In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
Table 89 North America In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
Table 90 North America In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
Table 91 North America In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
Table 92 North America In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
Table 93 North America In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
Table 94 North America In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 95 North America In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
Table 96 North America In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
Table 97 North America In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
Table 98 North America In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
Table 99 Europe In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
Table 100 Europe In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 101 Europe In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
Table 102 Europe In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 103 Europe In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
Table 104 Europe In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
Table 105 Europe In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
Table 106 Europe In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 107 Europe In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
Table 108 Europe In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
Table 109 Europe In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 110 Europe In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
Table 111 Europe In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
Table 112 Europe In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
Table 113 Europe In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
Table 114 Europe In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
Table 115 Europe In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 116 Europe In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
Table 117 Europe In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
Table 118 Europe In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
Table 119 Europe In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 120 Europe In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
Table 121 Europe In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
Table 122 Europe In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
Table 123 Europe In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
Table 124 Europe In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
Table 125 Europe In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
Table 126 Europe In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
Table 127 Europe In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
Table 128 Europe In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 129 Europe In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
Table 130 Europe In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
Table 131 Europe In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
Table 132 Europe In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
Table 133 Europe In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
Table 134 Europe In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
Table 135 Europe In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
Table 136 Europe In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
Table 137 Europe In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
Table 138 Europe In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
Table 139 Europe In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
Table 140 Europe In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
Table 141 Europe In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
Table 142 Europe In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
Table 143 Europe In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 144 Europe In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
Table 145 Europe In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
Table 146 Europe In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
Table 147 Europe In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
Table 148 Asia Pacific In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
Table 149 Asia Pacific In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 150 Asia Pacific In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
Table 151 Asia Pacific In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 152 Asia Pacific In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
Table 153 Asia Pacific In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
Table 154 Asia Pacific In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
Table 155 Asia Pacific In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 156 Asia Pacific In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
Table 157 Asia Pacific In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
Table 158 Asia Pacific In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 159 Asia Pacific In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
Table 160 Asia Pacific In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
Table 161 Asia Pacific In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
Table 162 Asia Pacific In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
Table 163 Asia Pacific In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
Table 164 Asia Pacific In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 165 Asia Pacific In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
Table 166 Asia Pacific In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
Table 167 Asia Pacific In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
Table 168 Asia Pacific In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 169 Asia Pacific In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
Table 170 Asia Pacific In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
Table 171 Asia Pacific In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
Table 172 Asia Pacific In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
Table 173 Asia Pacific In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
Table 174 Asia Pacific In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
Table 175 Asia Pacific In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
Table 176 Asia Pacific In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
Table 177 Asia Pacific In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 178 Asia Pacific In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
Table 179 Asia Pacific In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
Table 180 Asia Pacific In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
Table 181 Asia Pacific In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
Table 182 Asia Pacific In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
Table 183 Asia Pacific In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
Table 184 Asia Pacific In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
Table 185 Asia Pacific In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
Table 186 Asia Pacific In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
Table 187 Asia Pacific In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
Table 188 Asia Pacific In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
Table 189 Asia Pacific In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
Table 190 Asia Pacific In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
Table 191 Asia Pacific In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
Table 192 Asia Pacific In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 193 Asia Pacific In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
Table 194 Asia Pacific In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
Table 195 Asia Pacific In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
Table 196 Asia Pacific In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)
Table 197 RoW In Vitro Diagnostics Market Outlook, By Country (2013-2022) ($MN)
Table 198 RoW In Vitro Diagnostics Market Outlook, By Application (2013-2022) ($MN)
Table 199 RoW In Vitro Diagnostics Market Outlook, By Diabetes (2013-2022) ($MN)
Table 200 RoW In Vitro Diagnostics Market Outlook, By Autoimmune Diseases (2013-2022) ($MN)
Table 201 RoW In Vitro Diagnostics Market Outlook, By Cardiology (2013-2022) ($MN)
Table 202 RoW In Vitro Diagnostics Market Outlook, By Drug Testing (2013-2022) ($MN)
Table 203 RoW In Vitro Diagnostics Market Outlook, By HIV/AIDS (2013-2022) ($MN)
Table 204 RoW In Vitro Diagnostics Market Outlook, By Infectious Diseases (2013-2022) ($MN)
Table 205 RoW In Vitro Diagnostics Market Outlook, By Nephrology (2013-2022) ($MN)
Table 206 RoW In Vitro Diagnostics Market Outlook, By Oncology/Cancer (2013-2022) ($MN)
Table 207 RoW In Vitro Diagnostics Market Outlook, By Other Applications (2013-2022) ($MN)
Table 208 RoW In Vitro Diagnostics Market Outlook, By Product & Service (2013-2022) ($MN)
Table 209 RoW In Vitro Diagnostics Market Outlook, By Data Management Software/Hardware (2013-2022) ($MN)
Table 210 RoW In Vitro Diagnostics Market Outlook, By Instruments (2013-2022) ($MN)
Table 211 RoW In Vitro Diagnostics Market Outlook, By Reagents & Kits (2013-2022) ($MN)
Table 212 RoW In Vitro Diagnostics Market Outlook, By Services (2013-2022) ($MN)
Table 213 RoW In Vitro Diagnostics Market Outlook, By Technology (2013-2022) ($MN)
Table 214 RoW In Vitro Diagnostics Market Outlook, By Immunochemistry/Immunoassays (2013-2022) ($MN)
Table 215 RoW In Vitro Diagnostics Market Outlook, By Elisa (2013-2022) ($MN)
Table 216 RoW In Vitro Diagnostics Market Outlook, By Western Blot (2013-2022) ($MN)
Table 217 RoW In Vitro Diagnostics Market Outlook, By Rapid Tests (2013-2022) ($MN)
Table 218 RoW In Vitro Diagnostics Market Outlook, By Radioimmunoassays (RIA) (2013-2022) ($MN)
Table 219 RoW In Vitro Diagnostics Market Outlook, By Elispot (2013-2022) ($MN)
Table 220 RoW In Vitro Diagnostics Market Outlook, By Coagulation and Hemostasis (2013-2022) ($MN)
Table 221 RoW In Vitro Diagnostics Market Outlook, By Molecular Diagnostics (MDX) (2013-2022) ($MN)
Table 222 RoW In Vitro Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (2013-2022) ($MN)
Table 223 RoW In Vitro Diagnostics Market Outlook, By Hybridization (2013-2022) ($MN)
Table 224 RoW In Vitro Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2013-2022) ($MN)
Table 225 RoW In Vitro Diagnostics Market Outlook, By Microarrays (2013-2022) ($MN)
Table 226 RoW In Vitro Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2013-2022) ($MN)
Table 227 RoW In Vitro Diagnostics Market Outlook, By Other Molecular Diagnostics (2013-2022) ($MN)
Table 228 RoW In Vitro Diagnostics Market Outlook, By Hematology (2013-2022) ($MN)
Table 229 RoW In Vitro Diagnostics Market Outlook, By Microbiology (2013-2022) ($MN)
Table 230 RoW In Vitro Diagnostics Market Outlook, By Clinical Chemistry (2013-2022) ($MN)
Table 231 RoW In Vitro Diagnostics Market Outlook, By Electrolyte Panels (2013-2022) ($MN)
Table 232 RoW In Vitro Diagnostics Market Outlook, By Basic Metabolic Panel (2013-2022) ($MN)
Table 233 RoW In Vitro Diagnostics Market Outlook, By Lipid Profiles (2013-2022) ($MN)
Table 234 RoW In Vitro Diagnostics Market Outlook, By Liver Panels (2013-2022) ($MN)
Table 235 RoW In Vitro Diagnostics Market Outlook, By Renal Profiles (2013-2022) ($MN)
Table 236 RoW In Vitro Diagnostics Market Outlook, By Specialty Chemical Tests (2013-2022) ($MN)
Table 237 RoW In Vitro Diagnostics Market Outlook, By Thyroid Function Panels (2013-2022) ($MN)
Table 238 RoW In Vitro Diagnostics Market Outlook, By Other Technologies(2013-2022) ($MN)
Table 239 RoW In Vitro Diagnostics Market Outlook, By End-User (2013-2022) ($MN)
Table 240 RoW In Vitro Diagnostics Market Outlook, By Academic Institutes (2013-2022) ($MN)
Table 241 RoW In Vitro Diagnostics Market Outlook, By Hospitals (2013-2022) ($MN)
Table 242 RoW In Vitro Diagnostics Market Outlook, By Laboratories (2013-2022) ($MN)
Table 243 RoW In Vitro Diagnostics Market Outlook, By Patient Self-Testing (2013-2022) ($MN)
Table 244 RoW In Vitro Diagnostics Market Outlook, By Point-Of-Care Testing (2013-2022) ($MN)
Table 245 RoW In Vitro Diagnostics Market Outlook, By Other End-Users (2013-2022) ($MN)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report